|
US5849719A
(en)
*
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
|
US20030109469A1
(en)
*
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
DK0909323T3
(da)
|
1996-01-04 |
2007-05-21 |
Novartis Vaccines & Diagnostic |
Helicobacter pylori-bakterioferritin
|
|
CA2244946C
(en)
*
|
1996-01-30 |
2010-04-13 |
The Regents Of The University Of California |
Gene expression vectors which generate an antigen specific immune response and methods of using the same
|
|
US20030078223A1
(en)
*
|
1996-01-30 |
2003-04-24 |
Eyal Raz |
Compositions and methods for modulating an immune response
|
|
JP2000507225A
(ja)
*
|
1996-03-08 |
2000-06-13 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
ｍａｂ ３Ｅ１０ ならびにその突然変異体および／または機能性フラグメントを使用する送達システム
|
|
EP0930893B1
(en)
|
1996-10-11 |
2005-04-13 |
The Regents of The University of California |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU753688B2
(en)
*
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
EP1374894A3
(en)
*
|
1997-06-06 |
2004-09-22 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
JP4101888B2
(ja)
*
|
1997-06-06 |
2008-06-18 |
ダイナバックス テクノロジーズ コーポレイション |
免疫刺激オリゴヌクレオチド、その組成物およびその使用方法
|
|
US20040006034A1
(en)
*
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
EP1009413B1
(en)
*
|
1997-09-05 |
2007-02-14 |
The Regents Of The University Of California |
Use of immunostimulatory oligonucleotides for preventing or treating asthma
|
|
JP2002510644A
(ja)
*
|
1998-04-03 |
2002-04-09 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物
|
|
CA2328406A1
(en)
*
|
1998-05-14 |
1999-11-18 |
Hermann Wagner |
Methods for regulating hematopoiesis using cpg-oligonucleotides
|
|
IL139813A0
(en)
*
|
1998-05-22 |
2002-02-10 |
Loeb Health Res Inst At The Ot |
Methods and products for inducing mucosal immunity
|
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
CA2333750A1
(en)
*
|
1998-06-23 |
1999-12-29 |
Dale T. Umetsu |
Adjuvant therapy
|
|
US6693086B1
(en)
*
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
AU776288B2
(en)
*
|
1998-10-05 |
2004-09-02 |
Regents Of The University Of California, The |
Methods and adjuvants for stimulating mucosal immunity
|
|
EP1117433A1
(en)
*
|
1998-10-09 |
2001-07-25 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
|
ATE464907T1
(de)
|
1999-02-17 |
2010-05-15 |
Csl Ltd |
Immunogene komplexe und methoden in bezug auf diese
|
|
CA2363141C
(en)
|
1999-02-26 |
2010-04-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
|
ES2228454T3
(es)
|
1999-02-26 |
2005-04-16 |
Chiron S.R.L. |
Mejora de la actividad bacteriana de antigenos de neisseria con oligonucleotidos que contienen motivos cg.
|
|
US6977245B2
(en)
*
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
EP1176966B1
(en)
|
1999-04-12 |
2013-04-03 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Oligodeoxynucleotide and its use to induce an immune response
|
|
CN1227030C
(zh)
|
1999-04-19 |
2005-11-16 |
史密丝克莱恩比彻姆生物有限公司 |
包含皂甙和免疫刺激寡核苷酸的佐剂组合物
|
|
US6558670B1
(en)
|
1999-04-19 |
2003-05-06 |
Smithkline Beechman Biologicals S.A. |
Vaccine adjuvants
|
|
US6737066B1
(en)
*
|
1999-05-06 |
2004-05-18 |
The Immune Response Corporation |
HIV immunogenic compositions and methods
|
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
|
DE60041335D1
(de)
|
1999-08-19 |
2009-02-26 |
Dynavax Tech Corp |
Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
|
|
US6949520B1
(en)
*
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
JP2003512829A
(ja)
|
1999-10-22 |
2003-04-08 |
アヴェンティス パストゥール リミテッド |
改変型ｇｐ１００およびその使用
|
|
US8017742B2
(en)
*
|
1999-11-10 |
2011-09-13 |
Japan Science And Technology Agency |
Gene carrier
|
|
US7223398B1
(en)
*
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
|
DE60131430T2
(de)
|
2000-01-14 |
2008-10-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
|
WO2001095935A1
(en)
*
|
2000-01-20 |
2001-12-20 |
Ottawa Health Research Institute |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
|
AT409085B
(de)
*
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US7585847B2
(en)
*
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
US20040131628A1
(en)
*
|
2000-03-08 |
2004-07-08 |
Bratzler Robert L. |
Nucleic acids for the treatment of disorders associated with microorganisms
|
|
US7129222B2
(en)
*
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
|
EP1267618A1
(en)
|
2000-03-28 |
2003-01-02 |
The Regents Of The University Of California |
Methods for increasing a cytotoxic t lymphocyte response in vivo
|
|
CA2408328C
(en)
|
2000-05-10 |
2012-04-17 |
Aventis Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
|
DE60100814T2
(de)
*
|
2000-06-08 |
2004-07-01 |
Intercell Biomedizinische Forschungs- Und Entwicklungs Gmbh |
Immunstimulierende oligodeoxynukleotide
|
|
WO2001097843A2
(en)
|
2000-06-22 |
2001-12-27 |
University Of Iowa Research Foundation |
Methods for enhancing antibody-induced cell lysis and treating cancer
|
|
WO2002002172A1
(en)
*
|
2000-06-30 |
2002-01-10 |
Univ Jefferson |
Dna palindrome - oligoguanylic acid compositions and uses thereof
|
|
KR100917101B1
(ko)
*
|
2000-08-04 |
2009-09-15 |
도요 보세키 가부시키가이샤 |
플렉시블 금속적층체 및 그 제조방법
|
|
US6787524B2
(en)
*
|
2000-09-22 |
2004-09-07 |
Tanox, Inc. |
CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
|
|
DK2266603T3
(da)
|
2000-10-18 |
2012-11-05 |
Glaxosmithkline Biolog Sa |
Tumorvacciner
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
AU2002231336B2
(en)
*
|
2000-12-27 |
2007-06-28 |
Surefire Medical, Inc. D/B/A Trisalus Life Sciences |
Immunomodulatory polynucleotides and methods of using the same
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US8703146B2
(en)
*
|
2001-04-20 |
2014-04-22 |
Institute For Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
EP1379552B2
(en)
*
|
2001-04-20 |
2014-11-19 |
The Institute for Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
JP4188092B2
(ja)
|
2001-05-21 |
2008-11-26 |
インターツェル・アクチェンゲゼルシャフト |
免疫促進性オリゴデオキシ核酸分子
|
|
EP2842964A1
(de)
|
2001-06-05 |
2015-03-04 |
Curevac GmbH |
Virtuelles Verfahren zur Ermittlung einer modifzierten mRNA-Sequenz
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
US8114418B2
(en)
|
2001-06-21 |
2012-02-14 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—IV
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
WO2003012061A2
(en)
*
|
2001-08-01 |
2003-02-13 |
Coley Pharmaceutical Gmbh |
Methods and compositions relating to plasmacytoid dendritic cells
|
|
WO2003014316A2
(en)
|
2001-08-07 |
2003-02-20 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, formulations, and methods for use thereof
|
|
AU2002361468A1
(en)
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
|
CN1604795B
(zh)
|
2001-08-17 |
2010-05-26 |
科勒制药股份公司 |
具有提高的活性的组合基序免疫刺激寡肽
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
TW200303759A
(en)
*
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
|
AU2002366710A1
(en)
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
|
WO2003070909A2
(en)
|
2002-02-20 |
2003-08-28 |
Chiron Corporation |
Microparticles with adsorbed polypeptide-containing molecules
|
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
DE10229872A1
(de)
*
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
WO2004011650A2
(en)
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
SG172476A1
(en)
*
|
2002-08-12 |
2011-07-28 |
Dynavax Tech Corp |
Immunomodulatory compositions comprising a cationic condensing agent, an immunostimulatory compound comprising 5'-cg-3', an a non ionic detergent
|
|
ATE488246T1
(de)
*
|
2002-08-15 |
2010-12-15 |
3M Innovative Properties Co |
Immunstimulatorische zusammensetzungen und verfahren zur stimulierung einer immunantwort
|
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
WO2004024182A2
(en)
|
2002-09-13 |
2004-03-25 |
Intercell Ag |
Method for isolating hepatitis c virus peptides
|
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
|
BR0314629A
(pt)
|
2002-09-19 |
2005-08-02 |
Us Gov Health & Human Serv |
Polipeptìdeos de p. ariasi polipeptìdeos de p. perniciosus e métodos e uso
|
|
US7179797B2
(en)
*
|
2002-09-27 |
2007-02-20 |
Wisconsin Alumni Research Foundation |
Methods and compositions for treating prostate cancer using DNA vaccines
|
|
PL376792A1
(pl)
|
2002-10-23 |
2006-01-09 |
Glaxosmithkline Biologicals S.A. |
Sposoby szczepienia przeciwko malarii
|
|
CN1753687A
(zh)
|
2002-10-29 |
2006-03-29 |
科勒制药集团股份有限公司 |
Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
|
|
JP2006516187A
(ja)
|
2002-10-29 |
2006-06-29 |
アメリカ合衆国 |
ルツォーミアロンギパルピスポリペプチドおよび使用方法
|
|
AU2003304107B2
(en)
*
|
2002-11-01 |
2008-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
|
DK2279746T3
(da)
|
2002-11-15 |
2013-11-25 |
Novartis Vaccines & Diagnostic |
Overfladeproteiner i neisseria meningitidis
|
|
NZ540276A
(en)
*
|
2002-11-21 |
2007-12-21 |
Bayhill Therapeutics Inc |
Methods and immune modulatory nucleic acid compositions for preventing and treating disease
|
|
US10100316B2
(en)
*
|
2002-11-21 |
2018-10-16 |
Archemix Llc |
Aptamers comprising CPG motifs
|
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
US7354593B2
(en)
|
2002-12-09 |
2008-04-08 |
Merial Limited |
Coccidial vaccine and methods of making and using same
|
|
WO2004053104A2
(en)
|
2002-12-11 |
2004-06-24 |
Coley Pharmaceutical Group, Inc. |
5’ cpg nucleic acids and methods of use
|
|
ES2381309T3
(es)
|
2002-12-23 |
2012-05-25 |
Dynavax Technologies Corporation |
Secuencia de oligonucleótidos inmunoestimuladores y métodos para usar los mismos
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
JP2006516099A
(ja)
|
2002-12-23 |
2006-06-22 |
ダイナバックス テクノロジーズ コーポレイション |
分枝状の免疫調節化合物及び該化合物の使用方法
|
|
AU2003299994A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
|
US8193185B2
(en)
|
2003-01-21 |
2012-06-05 |
Novartis Vaccines And Diagnostics, Inc. |
Use of tryptanthrin compounds for immune potentiation
|
|
US7704514B2
(en)
|
2003-03-24 |
2010-04-27 |
Intercell Ag |
Vaccines
|
|
ES2423800T3
(es)
|
2003-03-28 |
2013-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos orgánicos para la inmunopotenciación
|
|
EP1608403A2
(en)
*
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
US7790189B2
(en)
*
|
2003-05-15 |
2010-09-07 |
Mitsui Sugar Co., Ltd. |
Immunostimulating agents
|
|
CA2528007C
(en)
|
2003-06-02 |
2012-03-27 |
Chiron Corporation |
Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
|
|
US20050013812A1
(en)
*
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
US20060035242A1
(en)
|
2004-08-13 |
2006-02-16 |
Michelitsch Melissa D |
Prion-specific peptide reagents
|
|
AU2004275876B2
(en)
|
2003-09-25 |
2011-03-31 |
Coley Pharmaceutical Gmbh |
Nucleic acid-lipophilic conjugates
|
|
GB0323968D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
SG122973A1
(en)
*
|
2003-10-30 |
2006-06-29 |
Coley Pharm Gmbh |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
|
EP1689858B1
(en)
|
2003-11-13 |
2013-05-15 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
US9090673B2
(en)
|
2003-12-12 |
2015-07-28 |
City Of Hope |
Synthetic conjugate of CpG DNA and T-help/CTL peptide
|
|
US20050175630A1
(en)
*
|
2003-12-23 |
2005-08-11 |
Eyal Raz |
Immunogenic compositions and methods of use thereof
|
|
PL1734992T3
(pl)
|
2004-01-21 |
2012-02-29 |
Merial Inc |
Ulepszone inaktywowane szczepionki fcv
|
|
US7973016B2
(en)
*
|
2004-01-23 |
2011-07-05 |
Joslin Diebetes Center |
Methods of treating, reducing, or preventing autoimmune conditions
|
|
EP1734975B1
(en)
|
2004-03-19 |
2015-06-10 |
Herbs Spring, LLC |
Herbal therapy for the treatment of food allergy
|
|
TWI235440B
(en)
*
|
2004-03-31 |
2005-07-01 |
Advanced Semiconductor Eng |
Method for making leadless semiconductor package
|
|
CA2567789A1
(en)
*
|
2004-06-08 |
2006-08-03 |
Coley Pharmaceutical Gmbh |
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
|
WO2006002422A2
(en)
|
2004-06-24 |
2006-01-05 |
Novartis Vaccines And Diagnostics Inc. |
Compounds for immunopotentiation
|
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
|
KR100958505B1
(ko)
*
|
2004-07-18 |
2010-05-17 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제
|
|
GB0417494D0
(en)
|
2004-08-05 |
2004-09-08 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
AU2005282889B2
(en)
|
2004-09-01 |
2012-03-15 |
Dynavax Technologies Corporation |
Methods and conpositions for inhibition of innate immune responses and autoimmunity
|
|
DE102004042546A1
(de)
*
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
DE602005020815D1
(de)
|
2004-09-24 |
2010-06-02 |
Intercell Ag |
Verändertes vp-1capsidprotein von parvovirus b19
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
SI2682126T1
(sl)
|
2005-01-27 |
2017-03-31 |
Children's Hospital & Research Center At Oakland |
Cepiva na osnovi veziklov, osnovanih na GNA1870, za širokospektralno zaščito proti boleznim, povzročenim z Neisserio meningitidisom
|
|
CN101171033A
(zh)
*
|
2005-03-04 |
2008-04-30 |
戴纳瓦克斯技术公司 |
包含具免疫刺激序列iss之寡核苷酸的疫苗：其中iss与抗原缀合并通过缓冲条件和其他赋形剂稳定
|
|
JP2008535862A
(ja)
|
2005-04-08 |
2008-09-04 |
キメリクス，インコーポレイテッド |
ポックスウイルス感染の治療のための化合物、組成物および方法
|
|
WO2006115843A2
(en)
|
2005-04-25 |
2006-11-02 |
Merial Limited |
Nipah virus vaccines
|
|
KR20130110233A
(ko)
|
2005-04-29 |
2013-10-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
결핵균 감염을 예방 또는 치료하기 위한 신규한 방법
|
|
GB0513421D0
(en)
|
2005-06-30 |
2005-08-03 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
ES2330884T3
(es)
|
2005-07-01 |
2009-12-16 |
Index Pharmaceuticals Ab |
Modulacion de la respuesta a los esteroides.
|
|
PL2380584T3
(pl)
|
2005-07-01 |
2014-03-31 |
Index Pharmaceuticals Ab |
Sposób do immunostymulacji
|
|
US20090117132A1
(en)
*
|
2005-07-07 |
2009-05-07 |
Pfizer, Inc. |
Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer Treatment
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
EP1940472A1
(en)
|
2005-10-28 |
2008-07-09 |
Index Pharmaceuticals AB |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
|
US11707520B2
(en)
|
2005-11-03 |
2023-07-25 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
PL1951299T3
(pl)
*
|
2005-11-04 |
2012-07-31 |
Novartis Ag |
Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
|
|
PL1945252T3
(pl)
|
2005-11-04 |
2013-11-29 |
Seqirus Uk Ltd |
Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant
|
|
US20070184068A1
(en)
|
2005-12-14 |
2007-08-09 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
AU2007211334A1
(en)
*
|
2006-02-01 |
2007-08-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
WO2007092315A2
(en)
*
|
2006-02-03 |
2007-08-16 |
The Regents Of The University Of California |
Immunostimulation by cpg oligonucleotide-virus complexes
|
|
DK1991678T4
(da)
*
|
2006-02-15 |
2020-10-19 |
Rechtsanwalt Thomas Beck |
Sammensætninger og fremgangsmåder til oligonukleotid-formuleringer
|
|
WO2007115059A2
(en)
|
2006-03-29 |
2007-10-11 |
Merial Limited |
Vaccine against streptococci
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
CN101466720B
(zh)
|
2006-06-12 |
2013-01-02 |
赛托斯生物技术公司 |
向rna噬菌体的病毒样颗粒内包装寡核苷酸的方法
|
|
EP2046954A2
(en)
|
2006-07-31 |
2009-04-15 |
Curevac GmbH |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
|
DE102006035618A1
(de)
*
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
|
HUE036180T2
(hu)
|
2006-09-26 |
2018-06-28 |
Infectious Disease Res Inst |
Szintetikus adjuvánst tartalmazó vakcina készítmény
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
KR101251707B1
(ko)
|
2006-09-27 |
2013-04-11 |
콜리 파마슈티칼 게엠베하 |
면역 자극 활성이 증강된 소수성 Ｔ 유사체를 함유하는 ＣｐＧ 올리고뉴클레오티드 유사체
|
|
US20090142362A1
(en)
*
|
2006-11-06 |
2009-06-04 |
Avant Immunotherapeutics, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
|
|
DK2094849T3
(en)
*
|
2006-11-09 |
2014-03-24 |
Dynavax Tech Corp |
LONG-TERM DISEASE MODIFICATION USING IMMUNSTIMULATORY OLIGONUCLEOTIDES
|
|
JP5389662B2
(ja)
|
2006-12-12 |
2014-01-15 |
サイトス バイオテクノロジー アーゲー |
高濃度のグアニン・モノマーを含有するオリゴヌクレオチド
|
|
CA2676143A1
(en)
|
2007-01-26 |
2008-07-31 |
University Of Louisville Research Foundation, Inc. |
Modification of exosomal components for use as a vaccine
|
|
HUE031411T2
(en)
|
2007-03-02 |
2017-07-28 |
Glaxosmithkline Biologicals Sa |
New Methods and Preparations
|
|
CA2688240A1
(en)
|
2007-05-24 |
2008-12-04 |
The United States Government As Represented By The Department Of Veterans Affairs |
Intranuclear protein transduction through a nucleoside salvage pathway
|
|
WO2009018500A1
(en)
*
|
2007-07-31 |
2009-02-05 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
ES2658347T3
(es)
|
2007-08-13 |
2018-03-09 |
Glaxosmithkline Biologicals Sa |
Vacunas
|
|
US20090196915A1
(en)
*
|
2007-08-21 |
2009-08-06 |
Gary Van Nest |
Composition and methods of making and using influenza proteins
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
CA2703931C
(en)
|
2007-10-26 |
2016-08-16 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
|
EP2244695A1
(en)
|
2007-12-07 |
2010-11-03 |
Novartis AG |
Compositions for inducing immune responses
|
|
CA2710534C
(en)
|
2008-01-31 |
2018-09-04 |
Curevac Gmbh |
Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
|
|
AU2009223613B2
(en)
|
2008-03-10 |
2014-09-25 |
Children's Hospital & Research Center At Oakland |
Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
|
|
AU2009246169B2
(en)
|
2008-05-15 |
2015-01-22 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
|
CA2725329C
(en)
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
CN102076358B
(zh)
|
2008-06-27 |
2016-08-17 |
硕腾有限责任公司 |
新颖的佐剂组合物
|
|
JP5722782B2
(ja)
|
2008-09-26 |
2015-05-27 |
ナノバイオ コーポレーション |
ナノエマルジョン治療用組成物及びその使用方法
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
CN102271704A
(zh)
|
2008-11-28 |
2011-12-07 |
梅里亚有限公司 |
重组禽流感疫苗及其用途
|
|
PE20110891A1
(es)
|
2008-12-09 |
2011-12-23 |
Pfizer Vaccines Llc |
Vacuna de peptido ch3 de ige
|
|
EP2396032B1
(en)
|
2009-02-10 |
2016-09-28 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
PL2402032T3
(pl)
|
2009-02-27 |
2020-03-31 |
Toray Industries, Inc. |
Kompozycja immunogenna
|
|
KR101715418B1
(ko)
|
2009-04-03 |
2017-03-10 |
메리얼 인코포레이티드 |
뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
|
|
HUE031051T2
(en)
|
2009-06-05 |
2017-06-28 |
Infectious Disease Res Inst |
Synthetic glycopyranosyl lipid adjuvant and vaccine compositions containing it
|
|
BRPI1014031A2
(pt)
|
2009-06-16 |
2018-02-20 |
Univ Michigan Regents |
vacinas de nanoemulsão
|
|
IN2012DN00446A
(enExample)
|
2009-07-30 |
2015-05-15 |
Pfizer Vaccines Llc |
|
|
CA2771540C
(en)
|
2009-08-21 |
2019-01-15 |
Merial Limited |
Recombinant avian paramyxovirus vaccine and method for making and using thereof
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
PE20121544A1
(es)
|
2009-09-03 |
2012-12-02 |
Pfizer Vaccines Llc |
Vacuna de pcsk9
|
|
NZ629256A
(en)
|
2009-12-22 |
2016-02-26 |
Celldex Therapeutics Inc |
Vaccine compositions
|
|
KR20120101572A
(ko)
|
2009-12-28 |
2012-09-13 |
메리얼 리미티드 |
재조합 ｎｄｖ 항원 및 이의 용도
|
|
EP3216789A1
(en)
|
2010-02-12 |
2017-09-13 |
Chimerix, Inc. |
Methods of treating viral infection
|
|
US20130197612A1
(en)
|
2010-02-26 |
2013-08-01 |
Jack W. Lasersohn |
Electromagnetic Radiation Therapy
|
|
EP2944322B1
(en)
|
2010-03-12 |
2018-01-17 |
Merial, Inc |
Bluetongue virus recombinant vaccines and uses thereof
|
|
GB201005005D0
(en)
|
2010-03-25 |
2010-05-12 |
Angeletti P Ist Richerche Bio |
New vaccine
|
|
BR122021020829B8
(pt)
|
2010-03-30 |
2022-12-27 |
Children´S Hospital & Res Center At Oakland |
Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada
|
|
EP2575868A1
(en)
|
2010-06-07 |
2013-04-10 |
Pfizer Vaccines LLC |
Ige ch3 peptide vaccine
|
|
US8658603B2
(en)
|
2010-06-16 |
2014-02-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inducing an immune response
|
|
US8940310B2
(en)
|
2010-06-16 |
2015-01-27 |
Dynavax Technologies Corporation |
Methods of treatment using TLR7 and/or TLR9 inhibitors
|
|
US8999349B2
(en)
*
|
2010-07-27 |
2015-04-07 |
The Regents Of The University Of California |
HMGB1-derived peptides enhance immune response to antigens
|
|
JP5948327B2
(ja)
|
2010-07-30 |
2016-07-06 |
キュアヴァック アーゲー |
トランスフェクションおよび免疫刺激のためのジスルフィド架橋されたカチオン性成分との核酸の複合体形成
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
BR112013004353B1
(pt)
|
2010-08-26 |
2022-04-26 |
Toray Industries, Inc |
Composições imunogênicas
|
|
EP4014989A1
(en)
|
2010-08-31 |
2022-06-22 |
Boehringer Ingelheim Animal Health USA Inc. |
Newcastle disease virus vectored herpesvirus vaccines
|
|
DK4108671T3
(da)
|
2010-10-01 |
2025-01-06 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer samt anvendelser deraf
|
|
EA201390676A1
(ru)
|
2010-11-08 |
2013-11-29 |
Инфекшес Дизиз Рисерч Инститьют |
Вакцины, содержащие полипептиды неспецифической нуклеозидгидролазы и стерол 24-c-метилтрансферазы (smt), для лечения и диагностики лейшманиоза
|
|
US20140004142A1
(en)
|
2011-03-02 |
2014-01-02 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
GB201106357D0
(en)
|
2011-04-14 |
2011-06-01 |
Pessi Antonello |
Composition and uses thereof
|
|
EP3632463A1
(en)
|
2011-04-08 |
2020-04-08 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
ES2764079T3
(es)
|
2011-05-27 |
2020-06-02 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacunas genéticas contra el virus Hendra y el virus Nipah
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US10752676B2
(en)
|
2011-09-16 |
2020-08-25 |
Ucb Biopharma Sprl |
Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficile
|
|
JP6113737B2
(ja)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
|
|
EP2596806A1
(en)
|
2011-11-25 |
2013-05-29 |
Index Pharmaceuticals AB |
Method for prevention of colectomy
|
|
PT2785374T
(pt)
|
2011-11-30 |
2019-05-09 |
Merial Ltd |
Vectores recombinantes do herpesvírus 3 dos galídeos (mdv serotipo 2) expressando antigénios de agentes patogénicos aviários e suas utilizações
|
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
WO2013119856A1
(en)
|
2012-02-07 |
2013-08-15 |
Infectious Disease Research Institute |
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
|
|
DK2814508T5
(da)
|
2012-02-14 |
2017-06-12 |
Merial Inc |
Rotavirus-underenhedsvacciner og fremgangsmåder til fremstilling og anvendelse deraf
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
EP2834259A4
(en)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
SI2850431T1
(en)
|
2012-05-16 |
2018-08-31 |
Immune Design Corp. |
Vaccines for hsv-2
|
|
EP2666785A1
(en)
|
2012-05-23 |
2013-11-27 |
Affiris AG |
Complement component C5a-based vaccine
|
|
RU2656187C2
(ru)
|
2012-06-13 |
2018-05-31 |
Мериал, Инк. |
Реассортантные btv и ahsv вакцины
|
|
CA2877817A1
(en)
|
2012-06-27 |
2014-01-03 |
Merial Limited |
Attenuated streptococcus suis vaccines and methods of making and use thereof
|
|
PT2874656T
(pt)
|
2012-07-17 |
2018-03-09 |
Merial Inc |
Vacinas atenuadas contra a gripe suína e métodos de fabricação e uso das mesmas
|
|
EP2703483A1
(en)
|
2012-08-29 |
2014-03-05 |
Affiris AG |
PCSK9 peptide vaccine
|
|
CN104768577B
(zh)
|
2012-08-30 |
2020-06-09 |
梅里亚有限公司 |
高压设备和用于制备灭活疫苗和用于重折叠/增溶重组蛋白的方法
|
|
WO2014040040A1
(en)
|
2012-09-10 |
2014-03-13 |
Merial Limited |
Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus ( derzsy's disease)
|
|
BR112015010364B1
(pt)
|
2012-11-08 |
2022-05-03 |
Boehringer Ingelheim Animal Health USA Inc. |
Vacinas atenuadas de mannheimia haemolytica e métodos de produção e uso
|
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
|
SG10201706147YA
(en)
|
2012-12-18 |
2017-08-30 |
Merial Inc |
High resolution melt genotyping of ibv, csfv and ndv
|
|
WO2014121096A1
(en)
|
2013-02-01 |
2014-08-07 |
Auburn University |
New modified live flavobacterium strains, stabilized vaccines comprising same, and methods of making and use thereof
|
|
CN110743008A
(zh)
|
2013-03-14 |
2020-02-04 |
哈佛大学的校长及成员们 |
基于纳米颗粒的组合物
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US9909114B2
(en)
|
2013-03-28 |
2018-03-06 |
Infectious Disease Research Institute |
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
|
|
CN105188741A
(zh)
|
2013-04-03 |
2015-12-23 |
阿勒丁医疗公司 |
新型纳米颗粒组合物
|
|
EP2986303B1
(en)
|
2013-04-18 |
2020-02-26 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
|
JP2016520077A
(ja)
|
2013-05-15 |
2016-07-11 |
ザ ガバナーズ オブ ザ ユニバーシティ オブ アルバータ |
Ｅ１ｅ２ｈｃｖワクチン及び使用方法
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
SG11201510746WA
(en)
|
2013-08-21 |
2016-03-30 |
Curevac Ag |
Respiratory syncytial virus (rsv) vaccine
|
|
RU2730011C2
(ru)
|
2013-09-19 |
2020-08-14 |
Зоэтис Сервисиз Ллс |
Адъюванты на масляной основе
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
WO2015066292A1
(en)
|
2013-11-01 |
2015-05-07 |
Merial Limited |
Attenuated pasteurella multocidavaccines & methods of making & use thereof
|
|
JP6306700B2
(ja)
|
2013-11-01 |
2018-04-04 |
ユニバーシティ オブ オスロＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｏｓｌｏ |
アルブミン改変体及びその使用
|
|
WO2015070207A2
(en)
|
2013-11-11 |
2015-05-14 |
The Government Of The United States, As Represented By The Secretary Of The Army |
Ama-1 epitopes, antibodies, compositions, and methods of making and using the same
|
|
US11452767B2
(en)
|
2013-11-15 |
2022-09-27 |
Oslo Universitetssykehus Hf |
CTL peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
|
|
WO2015077434A2
(en)
|
2013-11-20 |
2015-05-28 |
La Jolla Institute For Allergy And Immunology |
Pan pollen immunogens and methods and uses for immune response modulation
|
|
WO2015077442A2
(en)
|
2013-11-20 |
2015-05-28 |
La Jolla Institute For Allergy And Immunology |
Grass pollen immunogens and methods and uses for immune response modulation
|
|
WO2015092710A1
(en)
|
2013-12-19 |
2015-06-25 |
Glaxosmithkline Biologicals, S.A. |
Contralateral co-administration of vaccines
|
|
IL246456B2
(en)
|
2013-12-31 |
2024-06-01 |
Access To Advanced Health Inst |
Formulations will be assembled into a single vial
|
|
WO2015118789A1
(ja)
*
|
2014-02-06 |
2015-08-13 |
独立行政法人科学技術振興機構 |
ペプチド／β－１，３－グルカン複合体及びその製造方法並びにそれを含む医薬組成物
|
|
US10279019B2
(en)
|
2014-02-11 |
2019-05-07 |
Stc.Unm |
PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
|
|
WO2015131053A1
(en)
|
2014-02-28 |
2015-09-03 |
Alk-Abelló A/S |
Polypeptides derived from phl p and methods and uses thereof for immune response modulation
|
|
KR101924271B1
(ko)
|
2014-03-25 |
2019-02-22 |
메리얼 인코포레이티드 |
약독화된 히스토필러스 솜니를 함유하는 면역학적 조성물
|
|
WO2015149944A2
(en)
|
2014-04-01 |
2015-10-08 |
Curevac Gmbh |
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
|
|
US9713639B2
(en)
|
2014-05-19 |
2017-07-25 |
Merial, Inc. |
Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
|
|
WO2016057921A1
(en)
|
2014-10-10 |
2016-04-14 |
Baker Jr James R |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
|
FI3244920T3
(fi)
|
2015-01-16 |
2023-08-04 |
Zoetis Services Llc |
Suu- ja sorkkatautirokote
|
|
EP4226937A3
(en)
|
2015-03-05 |
2023-09-27 |
Northwestern University |
Non-neuroinvasive viruses and uses thereof
|
|
EP3294876A1
(en)
|
2015-05-14 |
2018-03-21 |
Merial, Inc. |
Method for porcine circovirus production and pcv2 vaccines
|
|
BR112017025562A2
(pt)
|
2015-05-29 |
2018-08-07 |
Merck Sharp & Dohme Corp. |
métodos para tratar câncer em um indivíduo e para tratar um indivíduo humano diagnosticado com câncer
|
|
US9981033B2
(en)
|
2015-06-23 |
2018-05-29 |
Merial Inc. |
PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
|
|
CN107949398A
(zh)
|
2015-06-26 |
2018-04-20 |
梅里亚股份有限公司 |
灭活的犬流感疫苗以及其制备方法和其用途
|
|
WO2017004168A1
(en)
|
2015-06-29 |
2017-01-05 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for treating cancer and promoting wound healing
|
|
EP3328394A4
(en)
|
2015-07-30 |
2019-03-13 |
ModernaTX, Inc. |
CONCATEMEE peptide epitope RNAs
|
|
MA42653A
(fr)
|
2015-08-20 |
2018-06-27 |
Merial Inc |
Vaccins recombinants contre le fcv et utilisations de ceux-ci
|
|
EP3341017B1
(en)
|
2015-08-25 |
2024-10-16 |
Babita Agrawal |
Immunomodulatory compositions comprising caulobacter crescentus and use thereof
|
|
RS65084B1
(sr)
|
2015-09-29 |
2024-02-29 |
Boehringer Ingelheim Animal Health Usa Inc |
Vakcine čestica sličnih virusu (vlp) parvovirusa pasa (cpv) i njihova upotreba
|
|
RU2702835C1
(ru)
|
2015-10-08 |
2019-10-11 |
Мериал, Инк. |
Живая ослабленная гетерологичная вакцина от leptospira
|
|
EP4491735A3
(en)
|
2015-10-08 |
2025-04-16 |
The Governors of the University of Alberta |
Hepatitis c virus e1/e2 heterodimers and methods of producing same
|
|
US10780158B2
(en)
|
2015-11-16 |
2020-09-22 |
Georgia State University Research Foundation, Inc. |
Tunable vaccine platform against pathogens of the paramyxovirus family
|
|
CA3006078A1
(en)
|
2015-11-23 |
2017-06-01 |
Merial, Inc. |
Fmdv and e2 fusion proteins and uses thereof
|
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
|
WO2017158421A1
(en)
|
2016-03-14 |
2017-09-21 |
University Of Oslo |
Anti-viral engineered immunoglobulins
|
|
CR20180445A
(es)
|
2016-03-14 |
2019-02-08 |
Univ Oslo |
Inmunoglobulinas diseñadas por ingeniería genética con unión alterada al fcrn
|
|
US10485857B2
(en)
|
2016-04-07 |
2019-11-26 |
Boehringer Ingelheim Animal Health USA Inc. |
Heartworm vaccine, methods and uses thereof
|
|
JP7089479B2
(ja)
|
2016-04-14 |
2022-06-22 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
抗菌性ポリアミド又はオクテニジン保存剤を含むマルチドーズ組成物
|
|
WO2017201390A1
(en)
|
2016-05-19 |
2017-11-23 |
The Regents Of The University Of Michigan |
Novel adjuvant compositions
|
|
US11780924B2
(en)
|
2016-06-21 |
2023-10-10 |
University Of Oslo |
HLA binding vaccine moieties and uses thereof
|
|
CN109863169A
(zh)
|
2016-08-23 |
2019-06-07 |
葛兰素史密丝克莱恩生物有限公司 |
具有连接至不变链(cd74)的短片段的抗原的融合肽
|
|
MX2019003035A
(es)
|
2016-09-16 |
2019-09-13 |
Infectious Disease Res Inst |
Vacunas que comprenden polipeptidos de mycobacterium leprae para la prevencion, el tratamiento y el diagnostico de la lepra.
|
|
EP3518966A1
(en)
|
2016-09-29 |
2019-08-07 |
GlaxoSmithKline Biologicals S.A. |
Compositions and methods of treatment of persistent hpv infection
|
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
|
WO2018096396A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Oslo |
Albumin variants and uses thereof
|
|
JP2020502080A
(ja)
|
2016-11-30 |
2020-01-23 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
弱毒ブタインフルエンザワクチン並びにその作製および使用方法
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
CN117357642A
(zh)
|
2016-12-14 |
2024-01-09 |
勃林格殷格翰动物保健美国公司 |
表达禽病原体的多种抗原的重组hvt载体及其用途
|
|
EP3391903B1
(en)
|
2017-04-21 |
2022-02-23 |
The Pirbright Institute |
Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens
|
|
CN111328289A
(zh)
|
2017-08-31 |
2020-06-23 |
勃林格殷格翰动物保健美国公司 |
预防生殖、育龄和生长猪的疾病的猪链球菌疫苗及其制备和使用方法
|
|
US12005112B2
(en)
|
2017-09-07 |
2024-06-11 |
University Of Oslo |
Vaccine molecules
|
|
EP3678698A1
(en)
|
2017-09-07 |
2020-07-15 |
University Of Oslo |
Vaccine molecules
|
|
CA3078223A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
WO2019173438A1
(en)
|
2018-03-06 |
2019-09-12 |
Stc. Unm |
Compositions and methods for reducing serum triglycerides
|
|
BR112020024285A2
(pt)
|
2018-06-12 |
2021-03-02 |
Glaxosmithkline Biologicals S.A. |
polinucleotídeos e polipeptídeos de adenovírus
|
|
EP3833382A1
(en)
|
2018-08-07 |
2021-06-16 |
GlaxoSmithKline Biologicals S.A. |
Processes and vaccines
|
|
WO2020128012A1
(en)
|
2018-12-21 |
2020-06-25 |
Glaxosmithkline Biologicals Sa |
Methods of inducing an immune response
|
|
CN113924111A
(zh)
|
2019-01-04 |
2022-01-11 |
勃林格殷格翰动物保健美国公司 |
减毒的支气管败血性博德特菌菌株、包含该减毒的菌株的口服疫苗及其制备和使用方法
|
|
WO2020243115A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
US20220396797A1
(en)
|
2019-11-15 |
2022-12-15 |
Infectious Disease Research Institute |
Rig-i agonist and adjuvant formulation for tumor treatment
|
|
WO2021099982A1
(en)
|
2019-11-22 |
2021-05-27 |
Glaxosmithkline Biologicals Sa |
Dosage and administration of a bacterial saccharide glycoconjugate vaccine
|
|
CN117120087A
(zh)
|
2020-12-23 |
2023-11-24 |
高级健康研究所 |
茄尼醇疫苗助剂及其制备方法
|
|
US20240299510A1
(en)
|
2020-12-31 |
2024-09-12 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteins
|
|
US12343375B2
(en)
|
2021-02-09 |
2025-07-01 |
University Of Louisville Research Foundation, Inc. |
Spray dried formulation of a cholera toxin B subunit variant
|
|
EP4313132A1
(en)
|
2021-03-31 |
2024-02-07 |
Vib Vzw |
Vaccine compositions for trypanosomatids
|
|
US20250009731A1
(en)
|
2021-11-08 |
2025-01-09 |
Nurix Therapeutics, Inc. |
Toll-like receptor therapy combinations with cbl-b inhibitor compounds
|